DrugDashboards

Nipride Rtu

Sodium Nitroprusside · SODIUM NITROPRUSSIDE .5 mg/mL · Injection, Solution · Intravenous · Exela Pharma Sciences, Llc

NDC 51754-1006-01 · 1 VIAL in 1 VIAL / 100 mL in 1 VIAL · NDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Exela Pharma Sciences, LLC., failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$55.00
Reported to Texas DSHS · 2026 annual filing · Exela Pharma Sciences

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA209387
TE code
AP
Approval date
Mar 8, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sodium Nitroprusside (Injection, Solution)

LabelerStrengthFirst seenLast seen
Exela Pharma Sciences, LlcSODIUM NITROPRUSSIDE .2 mg/mLJul 15, 2026Sep 2, 2026
Exela Pharma Sciences, LlcSODIUM NITROPRUSSIDE .5 mg/mLJul 15, 2026Sep 2, 2026
Hainan Poly Pharm. Co., Ltd.SODIUM NITROPRUSSIDE .5 mg/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.SODIUM NITROPRUSSIDE 50 mg/2mLJul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories Inc.,SODIUM NITROPRUSSIDE 50 mg/2mLJul 15, 2026Aug 31, 2026
Hainan Poly Pharm. Co., Ltd.SODIUM NITROPRUSSIDE .2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Nipride Rtu — NDC 51754-1006-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51754100601.

Free to cite with attribution — see how the data is put together.